AXSOME THERAPEUTICS, INC. (AXSM) Net Margin
- 2026-06-30: Net Margin -23.50%.
- 2026-03-31: Net Margin -33.76%.
- 2025-12-31: Net Margin -14.57%.
- 2025-09-30: Net Margin -27.62%.
Complete source-backed net margin history.
- Available history
- 2022-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -23.50% |
| 2026-03-31 | -33.76% |
| 2025-12-31 | -14.57% |
| 2025-09-30 | -27.62% |
| 2025-06-30 | -31.97% |
| 2025-03-31 | -48.91% |
| 2024-12-31 | -63.08% |
| 2024-09-30 | -61.67% |
| 2024-06-30 | -91.03% |
| 2024-03-31 | -91.14% |
| 2023-12-31 | -137.92% |
| 2023-09-30 | -107.62% |
| 2023-06-30 | -143.83% |
| 2023-03-31 | -11.86% |
| 2022-12-31 | -251.29% |
| 2022-09-30 | -266.08% |
| 2022-06-30 | -469.83% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -28.69% |
| 2024-12-31 | -74.47% |
| 2023-12-31 | -88.41% |
| 2022-12-31 | -373.99% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |